TITLE

A statistical analysis of factors predisposing patients to heparin resistance

AUTHOR(S)
Tanee Chan; Nian Chih Hwang; Chong Hee Lim
PUB. DATE
March 2006
SOURCE
Perfusion;Mar2006, Vol. 21 Issue 2, p99
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Heparin resistance (HR) is occasionally encountered in cardiac surgery. The objective of this study is to identify possible factors predisposing patients to heparin resistance. Four hundred patients scheduled for elective cardiac surgery requiring the use of cardiopulmonary bypass (CPB) were enrolled in this study. Data collection included: demographic data, types of preoperative anticoagulant/anti-platelet therapy, preoperative haemato-logical and biochemical laboratory results, medical condition, baseline activated clotting time (ACT) and infusion volume prior to heparinisation. Patients who require 5 mg/kg or more to achieve ACT greater than 400 seconds before CPB were considered to be heparin resistant. All data was tested with a preliminary univariate analysis and factors associated with HR (p value <0.05) were entered into a multivariate logistic regression analysis. Factors associated with HR with a p value <0.05 are considered predictors for HR. Thirty-two (8.0%) of the 400 patients fulfilled the criteria for HR. Preoperative heparin (p =0.025), low molecular weight heparin (p =0.049), plateletcount ≥300,000/ml (p =0.022) and albumin plasma concentration ≤35 g/dl 0, =0.044) are significantly associated with HR. HR patients also tend to require more volume replacement prior to CPB to maintain haemodynamic stability p =0.007).
ACCESSION #
20338362

 

Related Articles

  • Comparison of ACT point-of-care measurements: repeatability and agreement. Bosch, Y. P. J.; Ganushchak, Y. M.; de Jong, D. S. // Perfusion;Jan2006, Vol. 21 Issue 1, p27 

    Background: Accurate control of heparin anticoagulation is necessary during all stages of cardiopulmonary bypass (CPB). The activated clotting time, first described by Hattersley in 1966, is mostly used for determination of anticoagulation. Either celite or kaolin are used as activators. An ACT...

  • KardiohirurÅ¡ka procedúra kod bolesnika sa heparinom indukovanom trombocitopenijom (HIT II). Jović, M. D.; Nežić, D. G.; Čalija, B. M.; Nenadić, D. S.; Knežević, A. M.; Borzanović, M. D.; Krivokapić, B. M.; Petrović, I. M.; Djukanović, B. P. // Acta Chirurgica Iugoslavica;2009, Vol. 56 Issue 1, p47 

    Heparin-induced thrombocytopenia (HIT) might be life-threatening in patients undergoing open heart surgery, due to thromboembolic events, thrombocytopenia and bleeding. If cardiac surgery with cardiopulmonary bypass (CPB) is necessary, anticoagulation therapy will he based on usage of danaparoid...

  • Comparison between RapidTEG® and conventional thromboelastography in cardiac surgery patients. Thai, J.; Reynolds, E. J.; Natalia, N.; Cornelissen, C.; Lemmens, H. J. M.; Hill, C. C.; van der Starre, P. J. A. // BJA: The British Journal of Anaesthesia;Apr2011, Vol. 106 Issue 4, p605 

    No abstract available.

  • Prediction of Post-Weaning Fibrinogen Status during Cardiopulmonary Bypass: An Observational Study in 110 Patients. Erdoes, Gabor; Gerster, Germaine; Colucci, Giuseppe; Kaiser, Heiko; Alberio, Lorenzo; Eberle, Balthasar // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often leads to post-CPB bleeding. Though multifactorial in origin, this coagulopathy is often aggravated by deficient fibrinogen levels. Objective: To assess whether laboratory and thrombelastometric...

  • The relationship between heparin level and activated clotting time in the adult cardiac surgery population. FitzGerald, D. J.; Patel, A.; Body, S. C.; Garvin, S. // Perfusion;Mar2009, Vol. 24 Issue 2, p93 

    The purpose of this descriptive study was to examine the relationship between heparin levels (HL) determined by heparin protamine titration (HPT) and activated clotting time (ACT) for cardiopulmonary bypass (CPB) in an adult cardiac surgery population. We examined institutional databases for all...

  • Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population. FitzGerald, D. // Perfusion;Mar2009, Vol. 24 Issue 2, p97 

    Information about the issues discussed at the 30th Annual Seminar of the American Academy of Cardiovascular Perfusion held in Dallas, Texas from February 5-8, 2009 is presented. Topics include the relationship of heparin level and activated clotting time in the adult cardiac surgery populace....

  • Coagulation disorders of cardiopulmonary bypass: a review. Paparella, Domenico; Brister, Stephanie J.; Buchanan, Michael R. // Intensive Care Medicine;Oct2004, Vol. 30 Issue 10, p1873 

    Background: Postoperative bleeding is one of the most common complications of cardiac surgery.Discussion: Extensive surgical trauma, prolonged blood contact with the artificial surface of the cardiopulmonary bypass (CPB) circuit, high doses of heparin, and hypothermia...

  • Aortic valve replacement in a young patient with essential thrombocytosis. Ahmed, Kashif; Vohra, Hunaid A.; Milne, Alison; Langley, Stephen M. // Journal of Cardiothoracic Surgery;2008, Vol. 3, Special section p1 

    Essential Thrombocythcythaemia (ET) is an uncommon type of myeloproliferative disorder, characterised by both thrombotic and haemorrhagic diathesis. No clear guidelines exist for the pre-and post-operative management of patients undergoing cardiac surgery in the haematological and surgical...

  • Thrombocytopenia Associated with Antithrombotic Therapy in Patients with Cardiovascular Diseases: Diagnosis and Treatment. Kilickiran Avci, Burcak; Oto, Ali; Ozcebe, Osman // American Journal of Cardiovascular Drugs;2008, Vol. 8 Issue 5, p327 

    Agents with antiplatelet and anticoagulant activity have been proved to be effective in reducing the incidence of complications following acute coronary syndrome, percutaneous coronary intervention, and cardiopulmonary bypass. However, these agents, including heparin, glycoprotein IIb/IIIa...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics